A retrospective non interventional study on first line treatment for patientswWith BRAF V600E mutant metastatic colorectal cancer (mCRC) (CAPSTAN CRC)
A retrospective non interventional study on first line treatment for patientswWith BRAF V600E mutant metastatic colorectal cancer (mCRC) (CAPSTAN CRC)
CAPSTAN (mCRC in 1st line)
A retrospective non interventional study on first line treatment for patientswWith BRAF V600E mutant metastatic colorectal cancer (mCRC) (CAPSTAN CRC)
Status
Status :
Completed
Type of study
RWE
Min. Age
18
Years old
Max. Age
-
Gender
All
Therapeutic area :
Oncology
Disease :
Colorectal cancer
Phase :
RWE
Start Date :
April 12, 2020
End date :
December 05, 2021
Study ID :
NIS-PF0-2020-3141
CT.gov Number :
NCT04317599
Send by email